Advertisement

Clinical features and management of Meniere’s disease patients with drop attacks

  • Qianru Wu
  • Xuanyi Li
  • Yan Sha
  • Chunfu Dai
Otology

Abstract

Purpose

The aims of the present study are to investigate the variations in clinical features, including medical history, hearing function, vestibular function, and degree of endolymphatic hydrops (EH), in Meniere’s disease (MD) patients with and without drop attacks (DAs), and to examine the efficacy of intratympanic gentamicin (ITG) treatment in alleviating DAs.

Methods

In total, 177 unilateral definite MD patients, including 16 patients with DAs and 161 patients without DAs, were enrolled. The results of hearing test, vestibular-evoked myogenic potentials (VEMPs), and magnetic resonance imaging (MRI) were analyzed. Thirteen patients with DAs received a single ITG treatment and were followed up.

Results

The disease course of MD in the DA group was significantly longer than that in the control group (p = 0.007). MD patients with DAs had significantly greater hearing loss and worse EH than MD patients without DAs (p < 0.05). However, there was no between-group difference in vestibular function. In the study, 92.31% of refractory definite MD patients with DAs achieved satisfactory control of DAs after ITG treatment.

Conclusions

MD patients with DAs tend to suffer from severe hearing loss and a significant degree of EH in the inner ear. However, the vestibular function of MD patients with DAs may not be completely abolished, but be sensitive to stimulating signals. ITG treatment, which helps to decrease vestibular sensitivity, was an effective treatment to control DAs.

Keywords

Tumarkin attack Vertigo Endolymphatic hydrops Otolithic organ 

Notes

Acknowledgements

This work was supported by the National Natural Science Foundation of China (no. 81570917 [C. F. D.]).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in the present study involving human participants were approved by the medical ethics committee of the Eye, Ear, Nose & Throat Hospital and in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

All patients included in the study signed the informed consent. For this type of study formal consent is not required.

References

  1. 1.
    Tumarkin A (1936) The otolithic catastrophe: a new syndrome. Br Med J 2:175–177CrossRefGoogle Scholar
  2. 2.
    Black FO, Effron MZ, Burns DS (1982) Diagnosis and management of drop attacks of vestibular origin: Tumarkin’s otolithic crisis. Otolaryngol Head Neck Surg 90:256–262CrossRefGoogle Scholar
  3. 3.
    Baloh RW, Jacobson K, Winder T (1990) Drop attacks with Meniere’s syndrome. Ann Neurol 28:384–387CrossRefGoogle Scholar
  4. 4.
    Janzen VD, Russell RD (1988) Conservative management of Tumarkin’s otolithic crisis. J Otolaryngol 17:359–361PubMedGoogle Scholar
  5. 5.
    Hallpike CS, Cairns H (1938) Observations on the pathology of Meniere’s syndrome: (section of otology). Proc R Soc Med 31:1317–1336PubMedPubMedCentralGoogle Scholar
  6. 6.
    Nakashima T, Naganawa S, Sugiura M et al (2007) Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope 117:415–420CrossRefGoogle Scholar
  7. 7.
    Merchant SN, Adams JC, Nadol JJ (2005) Pathophysiology of Meniere’s syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 26:74–81CrossRefGoogle Scholar
  8. 8.
    Perez-Fernandez N, Montes-Jovellar L, Cervera-Paz J, Domenech-Vadillo E (2010) Auditory and vestibular assessment of patients with Meniere’s disease who suffer Tumarkin attacks. Audiol Neurootol 15:399–406CrossRefGoogle Scholar
  9. 9.
    Liu B, Leng Y, Zhou R et al (2016) Intratympanic steroids injection is effective for the treatment of drop attacks with Meniere’s disease and delayed endolymphatic hydrops: a retrospective study. Medicine (Baltimore) 95:e5767CrossRefGoogle Scholar
  10. 10.
    Viana LM, Bahmad F, Rauch SD (2014) Intratympanic gentamicin as a treatment for drop attacks in patients with Meniere’s disease. Laryngoscope 124:2151–2154CrossRefGoogle Scholar
  11. 11.
    Rah YC, Han JJ, Park J, Choi BY, Koo JW (2015) Management of intractable Meniere’s disease after intratympanic injection of gentamicin. Laryngoscope 125:972–978CrossRefGoogle Scholar
  12. 12.
    De Beer L, Stokroos R, Kingma H (2007) Intratympanic gentamicin therapy for intractable Meniere’s disease. Acta Otolaryngol 127:605–612CrossRefGoogle Scholar
  13. 13.
    Liu H, Zhang T, Wu Q, Zhang Y, Dai C (2017) End-point indicators of low-dose intratympanic gentamicin in management of Meniere’s disease. Acta Otolaryngol 137:136–143CrossRefGoogle Scholar
  14. 14.
    Patel M, Agarwal K, Arshad Q et al (2016) Intratympanic methylprednisolone versus gentamicin in patients with unilateral Meniere’s disease: a randomised, double-blind, comparative effectiveness trial. Lancet 388:2753–2762CrossRefGoogle Scholar
  15. 15.
    Schuknecht HF (1956) Ablation therapy for the relief of Meniere’s disease. Laryngoscope 66:859–870CrossRefGoogle Scholar
  16. 16.
    Demarco RC, Rossato M, de Oliveira JAA, Hyppolito MA (2011) Histological effects of intratympanic gentamicin on the vestibular organ of guinea pigs. J Laryngol Otol 125:357–362CrossRefGoogle Scholar
  17. 17.
    Hirvonen TP, Minor LB, Hullar TE, Carey JP (2005) Effects of intratympanic gentamicin on vestibular afferents and hair cells in the chinchilla. J Neurophysiol 93:643–655CrossRefGoogle Scholar
  18. 18.
    Lopez-Escamez JA, Carey J, Chung WH et al (2015) Diagnostic criteria for Meniere’s disease. J Vestib Res 25:1–7PubMedGoogle Scholar
  19. 19.
    Zhou YJ, Wu YZ, Cong N et al (2017) Contrasting results of tests of peripheral vestibular function in patients with bilateral large vestibular aqueduct syndrome. Clin Neurophysiol 128:1513–1518CrossRefGoogle Scholar
  20. 20.
    Wu Q, Dai C, Zhao M, Sha Y (2016) The correlation between symptoms of definite Meniere’s disease and endolymphatic hydrops visualized by magnetic resonance imaging. Laryngoscope 126:974–979CrossRefGoogle Scholar
  21. 21.
    Nakashima T, Naganawa S, Pyykkö I et al (2009) Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Oto-laryngol 129:5–8CrossRefGoogle Scholar
  22. 22.
    Ishiyama G, Ishiyama A, Jacobson K, Baloh RW (2001) Drop attacks in older patients secondary to an otologic cause. Neurology 57:1103–1106CrossRefGoogle Scholar
  23. 23.
    Ballester M, Liard P, Vibert D, Hausler R (2002) Meniere’s disease in the elderly. Otol Neurotol 23:73–78CrossRefGoogle Scholar
  24. 24.
    Colebatch JG, Halmagyi GM (1992) Vestibular evoked potentials in human neck muscles before and after unilateral vestibular deafferentation. Neurology 42:1635–1636CrossRefGoogle Scholar
  25. 25.
    Iwasaki S, McGarvie LA, Halmagyi GM et al (2007) Head taps evoke a crossed vestibulo-ocular reflex. Neurology 68:1227–1229CrossRefGoogle Scholar
  26. 26.
    Huang CH, Young YH (2012) Ocular and cervical vestibular-evoked myogenic potentials in Tumarkin falls. Otol Neurotol 33:1251–1256CrossRefGoogle Scholar
  27. 27.
    Timmer FC, Zhou G, Guinan JJ, Kujawa SG, Herrmann BS, Rauch SD (2006) Vestibular evoked myogenic potential (VEMP) in patients with Meniere’s disease with drop attacks. Laryngoscope 116:776–779CrossRefGoogle Scholar
  28. 28.
    Salt AN, Hirose K (2018) Communication pathways to and from the inner ear and their contributions to drug delivery. Hear Res 362:25–37CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Otology and Skull Base Surgery, Hearing Research Key Lab of Health Ministry of China, Eye and Ear Nose and Throat HospitalFudan UniversityShanghaiChina
  2. 2.Department of OtolaryngologyThe Affiliated Hospital of Xuzhou Medical CollegeXuzhouChina
  3. 3.Department of Radiology, Eye and Ear Nose and Throat HospitalFudan UniversityShanghaiChina

Personalised recommendations